Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma Of Esophagus

Explore clinical trials studying Adenocarcinoma Of Esophagus. Study availability and eligibility vary by location and protocol.

256 public trials 61 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma Of Esophagus trial results

Recruiting

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

NCT06203600

Conditions
Adenocarcinoma Of Esophagus, Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, +14 more
Locations
  • Baptist Health Medical Center - Little Rock Little Rock, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Kaiser Permanente-Baldwin Park Baldwin Park, California, United States
View all 374 locations
View Trial Details
Recruiting

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

NCT07182149

Conditions
Adenocarcinoma Of Esophagus, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Normunity Investigational Site Denver, Colorado, United States
  • Normunity Investigational Site New Haven, Connecticut, United States
  • Normunity Investigational Site Minneapolis, Minnesota, United States
  • Normunity Investigational Site Maumee, Ohio, United States
View all 18 locations
View Trial Details
Recruiting

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

NCT07392892

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations
  • Rocky Mountain Cancer Centers, LLP Aurora, Colorado, United States
  • Rocky Mountain Cancer Centers, LLP Boulder, Colorado, United States
  • Rocky Mountain Cancer Centers, LLP Centennial, Colorado, United States
  • Rocky Mountain Cancer Centers, LLP Colorado Springs, Colorado, United States
View all 74 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

NCT07221149

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations
  • Local Institution - 0284 Phoenix, Arizona, United States
  • Local Institution - 0437 Los Angeles, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center Orange, California, United States
  • Local Institution - 0428 San Francisco, California, United States
View all 161 locations
View Trial Details
Recruiting

Obeticholic Acid for Prevention in Barrett's Esophagus

NCT04939051

Conditions
Adenocarcinoma Of Esophagus, Barrett Esophagus, Digestive System Diseases, +5 more
Locations
  • University of Kansas Cancer Center Kansas City, Kansas, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
View Trial Details
Recruiting

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

NCT06324357

Conditions
Adenocarcinoma Of Esophagus, Breast Diseases, Breast Neoplasms, +18 more
Locations
  • The Oncology Institute of Hope and Innovation Cerritos, California, United States
  • Ellison Medical Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
View all 105 locations
View Trial Details
Recruiting

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NCT07277413

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of Esophagus, Adenoma, +55 more
Locations
  • Providence Medical Foundation Santa Rosa, California, United States
  • Johns Hopkins Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • BRCR Global-Coral Springs Coral Springs, Florida, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
View all 17 locations
View Trial Details
Recruiting

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

NCT05677490

Conditions
Adenocarcinoma Of Esophagus, Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, +13 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 793 locations
View Trial Details

Related conditions